Benign Gynecological Conditions in Transgender and Gender Diverse People

Context, Principles and Practice of TransGynecology Buy print or eBook [Opens in a new window] Managing Transgender Patients in ObGyn Practice - Context, Principles, and Practice of Transgynecology - Context, Principles, and Practice of Transgynecology - Copyright page - Dedication - Contents - Foreword - Preface - Contributors - Abbreviations - Section A Contextual Transgynecology - Section B Practicing Transgynecology - Chapter 9 Gynecological Office Medicine for Trans and Gender Diverse People - Chapter 10 Features of Imaging in Transgender Persons - Chapter 11 Benign Gynecological Conditions in Transgender and Gender Diverse People - Chapter 12 Urogynecological Disorders - Chapter 13 Painful and Frequent Micturition - Chapter 14 Diagnostics and Treatment of Gynecological and Nongynecological Causes of Pelvic Pain - Chapter 15 Gynecological Attention to the Prostate - Chapter 16 Vaginal Dilators and Dilating after Vaginoplasty - Chapter 17 Transenology - Section C Gynecological Surgery for Transgender Males - Section D Sexuality and Contraception - Section E Fertility and Reproduction - Section F Impact of Gender-affirming Hormonal Therapy on Genital Organs - Section G Screening and Prophylaxis - Transgynecology Index - References from Section B - Practicing Transgynecology Published online by Cambridge University Press: 22 December 2022 Book contents - Context, Principles, and Practice of Transgynecology - Context, Principles, and Practice of Transgynecology - Copyright page - Dedication - Contents - Foreword - Preface - Contributors - Abbreviations - Section A Contextual Transgynecology - Section B Practicing Transgynecology - Chapter 9 Gynecological Office Medicine for Trans and Gender Diverse People - Chapter 10 Features of Imaging in Transgender Persons - Chapter 11 Benign Gynecological Conditions in Transgender and Gender Diverse People - Chapter 12 Urogynecological Disorders - Chapter 13 Painful and Frequent Micturition - Chapter 14 Diagnostics and Treatment of Gynecological and Nongynecological Causes of Pelvic Pain - Chapter 15 Gynecological Attention to the Prostate - Chapter 16 Vaginal Dilators and Dilating after Vaginoplasty - Chapter 17 Transenology - Section C Gynecological Surgery for Transgender Males - Section D Sexuality and Contraception - Section E Fertility and Reproduction - Section F Impact of Gender-affirming Hormonal Therapy on Genital Organs - Section G Screening and Prophylaxis - Transgynecology Index - References Complaints related to endometriosis, irregular vaginal bleeding, fibroids, chronic recurrent colpitis, urinary tract infections or other benign gynecological conditions can be a heavy burden for patients regardless of one’s gender identity or gender role, but may evolve into an additional source of distress, physically and emotionally, for transgender and gender diverse people. Healthcare professionals tend to focus on gender incongruence and mitigating symptoms of gender dysphoria, and therefor do not always pay attention to chronic medical conditions to the extent necessary, especially in younger patients. Diagnostics and treatment of these conditions are not fundamentally different in transgender and gender diverse people, but the stage of transition and the goals of the process towards a satisfactory life, congruent with one’s gender identity, have to be taken into account. Treatment of chronic disorders in general and gynecological complaints in particular should be put into context (of gender-affirmative treatment) and collaboration with other healthcare professionals, including mental healthcare professionals (MHPs), should be sought out to ensure best possible care. This chapter addresses common benign gynecological conditions and treatment modalities for trans masculine and gender diverse people. - Type - Chapter - Information - Context, Principles and Practice of TransGynecologyManaging Transgender Patients in ObGyn Practice, pp. 82 - 88Publisher: Cambridge University PressPrint publication year: 2022 Zou, Y, Szczesniak, R, Teeters, A, Conard, LA, Grossoehme, D. Documenting an epidemic of suffering: low health-related quality of life among transgender youth. Qual Life Res 2018;27(8):2107–2115.CrossRefGoogle ScholarPubMed Mirabella, M, Giovanardi, G, Fortunato, A, et al. The body I live in. Perceptions and meanings of body dissatisfaction in young transgender adults: a qualitative study. J Clin Med 2020;9(11):3733.Google Scholar Battegay, E, Bassetti, S. Dissimulation und Maskierung von Symptomen und Befunden. In Battegay, E, Ed. Differenzialdiagnose Innerer Krankheiten. Stuttgart: Thieme, 2017, p. 50.Google Scholar Defreyne, J, Vanwonterghem, Y, Collet, S, et al. Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: a prospective cohort study (ENIGI). Int J Transgend Health 2020;21(2):163–175.Google Scholar Sitruk Ware, R. Pharmacological profile of progestins. Maturitas 2008;61(1–2):151–157.CrossRefGoogle ScholarPubMed Chu, MC, Zhang, X, Gentzschein, E, Stanczyk, KZ, Lobo, RA. Formation of ethinyl estradiol in women during treatment with norethindrone acetate. J Clin Endocrinol Metab 2007;92(6):2205–2207.CrossRefGoogle ScholarPubMed Hawkins, M, Deutsch, MB, Obedin-Maliver, J, et al. Endometrial findings among transgender and gender nonbinary people using testosterone at the time of gender-affirming hysterectomy. Fertil Steril 2021;115(5):1312–1317.CrossRefGoogle ScholarPubMed Ahrendt, HJ, Tylkoski, H, Rabe, T, et al. Prevalence of uterine myomas in women in Germany: data of an epidemiological study. Arch Gyn Obst 2016;293:1243–1253.CrossRefGoogle ScholarPubMed Stewart, EA, Cookson, CL, Gandolfo, RA, Schulze-Rath, R. Epidemiology of uterine fibroids: a systematic review. BJOG 2017;124(10):1501–1512.Google Scholar Fasih, N, Shanbhogue, AKP, Macdonald, DB, et al. Leiomyomas beyond the uterus: unusual locations, rare manifestations. Radiographics 2008;28:1931–1948.Google Scholar Pallavee, P, Seetesh, G, Samal, S, Begum, J, Zabeen, M. Fibroid after hysterectomy: a diagnostic dilemma. J Clin Diagn Res 2014;8(7):OD01–OD02.Google Scholar Donnez, J, Dolmans, MM. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016;22(6): 665–686.CrossRefGoogle ScholarPubMed Blake, RE. Leiomyomata uteri: hormonal and molecular determinants of growth. J Natl Med Assoc 2007;9(10):1170–1178.Google Scholar Ke, LQ, Yang, K, Li, J, Li, CM. Danazol for uterine fibroids. Cochrane Database Syst Rev 2009;2009:CD007692.Google ScholarPubMed Lan, M, Li, H, Bao, L, et al. In vivo evidence of the androgen receptor in association with myometrial cell proliferation and apoptosis. Reprod Sci 2016;23(2):264–271.CrossRefGoogle ScholarPubMed Bulun, SE, Imir, G, Utsunomiya, H, et al. Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Molec Biol 2005;95:57–62.CrossRefGoogle ScholarPubMed Wong, JYY, Gold, EB, Johnson, WO, Lee, JS. Circulating sex hormones and risk of uterine fibroids: Study of Women’s Health Across the Nation (SWAN). J Clin Endocrinol Metab 2016;101(1):123–130.CrossRefGoogle ScholarPubMed Sadowski, EA, Paroder, V, Patel-Lippmann, K, et al. Indeterminate adnexal cysts at US: prevalence and characteristics of ovarian cancer. Radiology 2018;287(3):1041–1049.CrossRefGoogle ScholarPubMed Timmerman, D, Valentin, L, Bourne, TH, et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000;16(5):500–505.Google Scholar Van Trotsenburg, M. Necessity and validity of transabdominal ultrasound for FtMs. Presentation at the session on gynecology, WPATH biennial symposium, September 2011, Atlanta (not yet published).Google Scholar Deswal, R, Narwal, V, Dang, A, Pundir, CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci 2020;13(4):261–271.Google Scholar Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19–25.CrossRefGoogle Scholar Khorshidi, A, Azami, M, Tardeh, S, Tardeh, Z. The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Diabetes Metab Syndr 2019;13(4):2747–2753.Google Scholar Moghetti, F, Tosi, F. Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest 2021;44(2):233–244.CrossRefGoogle ScholarPubMed Sanchez-Garrido, MA, Tena-Sempere, M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 2020;35:100937.Google Scholar Diamanti-Kandarakis, E, Papalou, O, Kandaraki, EA. The role of androgen excess on insulin sensitivity in women. In Pasquali, R, Pignatelli, D, Eds. Hyperandrogenism in Women. Beyond Polycystic Ovary Syndrome. Basel: Karger, 2019;53:50–64.Google Scholar Caanen, MR, Schouten, NE, Kuijper, EM, et al. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals. Hum Reprod 2017;32(7):1457–1464.CrossRefGoogle ScholarPubMed Mück, AO, Seeger, H. Hormone therapy after endometrial cancer. Endocr Rel Cancer 2004;11(2):305–314.Google Scholar Pillay, OC, Wong Te Fonf, LF, Crow, JC, et al. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006;21(4):924–929.CrossRefGoogle ScholarPubMed Skorska, MA, Bogaert, AF. Prenatal androgens in men’s sexual orientation: evidence for a more nuanced role. Arch Sex Behav 2017;46:1621–1624.Google Scholar Dörner, G, Götz, F, Rohde, W, et al. Genetic and epigenetic effects on sexual brain organization mediated by sex hormones. Neuro Endocrinol Lett 2001;22(6):403–409.Google Scholar Bosinski, HA, Peter, M, Bonatz, G, et al. A higher rate of hyperandrogenic disorders in female-to-male transsexuals. Psychoneuroendocrinology 1997;22(5):361–380.Google Scholar Amerikia, H, Savoy-Moore, RT, Sundareson, AS, Moghissi, KS. The effects of long-term androgen treatment on the ovary. Fertil Steril 1986;45(29):202–208.Google Scholar Ikeda, K, Baba, T, Noguchi, H, et al. Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. Hum Reprod 2013;28(2):453–461.Google Scholar Ghai, V, Haider, J, Fevzi, S, Haines, P, Kent, A. Diagnostic delay for superficial and deep endometriosis in the United Kingdom. J Obstet Gynaecol 2020;40(1):83–89.Google Scholar Zondervan, KT, Becker, CM, Missmer, SA. Endometriosis. N Engl J Med 2020;382(13):1244–1256.Google Scholar Ferrando, CA, Chapman, G, Pollard, R. Preoperative pain symptoms and the incidence of endometriosis in transgender men undergoing hysterectomy for gender affirmation. J Minim Invas Gynecol 2021;28(9):1579–1584.Google Scholar Serdar, E, Bulun, SE, Monsavais, D, et al. Role of estrogen receptor-β in endometriosis. Semin Reprod Med 2012;30(1):39–45.Google Scholar Patel, S. Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: a comprehensive review. J Steroid Biochem Mol Biol 2017;168:19–25.Google Scholar Słopień, R, Męczekalski, B. Review on aromatase inhibitors in the treatment of endometriosis. Menopause Rev 2016;15(1):43–47.Google Scholar Yanyan-Hong, Y, Chen, S. Aromatase inhibitors. Structural features and biochemical characterization. Ann NY Acad Sci 2006;1089:237–251.Google Scholar Meriggiola, MC, Armillotta, F, Costantino, A, et al. Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals. J Sex Med 2008;5(10):2442–2453.Google Scholar Shim, JY, Laufer, MR, Grimstad, FW. Dysmenorrhea and endometriosis in transgender adolescents. J Pediatr Adolesc Gynecol 2020;33(5):524–528.Google Scholar Accessibility compliance for the HTML of this chapter is currently unknown and may be updated in the future. To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle. Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply. Find out more about the Kindle Personal Document Service. - Benign Gynecological Conditions in Transgender and Gender Diverse People - - Book: Context, Principles and Practice of TransGynecology - Online publication: 22 December 2022 To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox. - Benign Gynecological Conditions in Transgender and Gender Diverse People - - Book: Context, Principles and Practice of TransGynecology - Online publication: 22 December 2022 To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive. - Benign Gynecological Conditions in Transgender and Gender Diverse People - - Book: Context, Principles and Practice of TransGynecology - Online publication: 22 December 2022